$7.45
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Ocular Therapeutix Stock Guidance | NASDAQ:OCUL | Benzinga
Ocular Therapeutix issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/07/2023 | OCUL | Ocular Therapeutix | FY | 2023 | — | — | — | $60.00M | $60.00M | $59.95M | Get Alert |
| 08/07/2023 | OCUL | Ocular Therapeutix | FY | 2023 | — | — | — | $55.00M | $60.00M | $59.05M | Get Alert |
| 05/08/2023 | OCUL | Ocular Therapeutix | FY | 2023 | — | — | — | $55.00M | $60.00M | $58.80M | Get Alert |
| 03/06/2023 | OCUL | Ocular Therapeutix | FY | 2023 | — | — | — | $55.00M | $60.00M | $69.98M | Get Alert |
| 07/22/2021 | OCUL | Ocular Therapeutix | Q2 | 2021 | — | — | — | $11.70M | $11.70M | $11.60M | Get Alert |
| 10/07/2020 | OCUL | Ocular Therapeutix | Q3 | 2020 | — | — | — | $5.80M | $5.90M | $3.91M | Get Alert |
| 07/17/2020 | OCUL | Ocular Therapeutix | Q2 | 2020 | — | — | — | $1.60M | $1.60M | $1.08M | Get Alert |
FAQ
What is the most recent guidance for Ocular Therapeutix (OCUL)?
There have been no specific sales or earnings guidance reported for Ocular Therapeutix in recent months.
Browse guidance and forecast on all stocks.